Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio ...
Equity Insider News Commentary – The oncology sector's pivot toward platform-based precision therapies has signaled smart money ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback